Outreach Core

外展核心摘要 西班牙裔/拉丁美洲人患晚期癌症的风险更高，诊断后的生存率更差， 拉丁裔白人减少西班牙裔/拉丁裔之间的癌症差异需要传播基于证据的 制定癌症预防和控制战略，并制定证据支持新的战略。我们推测 一个有效的和文化上敏感的方法来减少西班牙裔/拉丁美洲人的癌症负担是， link美国国家癌症研究所（NCI）-指定的癌症中心和服务不足的机构 联邦合格卫生中心（FATHCs）。因此，我们建议建立三边伙伴关系， 在加州圣地亚哥大学（UCSD）Moores癌症中心、圣地亚哥州立大学（SDSU）、 和圣地亚哥家庭健康中心（FHCSD），一个每年在圣地亚哥为130，000多人提供服务的家庭健康中心。 迭戈县。我们建议增加乳腺癌、宫颈癌和结直肠癌的筛查和诊断随访 癌症主要是西班牙裔/拉丁裔社区通过以下目标。首先，我们将一个社区 卫生工作者（推广者）主导的癌症筛查干预，患者导航，以提高筛查率。 Promotora癌症筛查干预建立在一项随机对照试验的结果之上， 提高拉丁裔教徒的癌症筛查率，并将通过包括广泛的 社区组织为西班牙裔/拉丁裔社区以及西班牙裔/拉丁裔男子提供服务， 努力第二，我们将优化乳腺、宫颈和结直肠异常的完整诊断评估 通过实施以证据为基础的最佳做法进行癌症筛查。具体而言，在伙伴关系中， 通过FHCSD，我们将使用患者导航策略来建立现有的病例管理 基础设施，以促进对异常测试结果的完整诊断评估。第三，我们建议 通过认证的社区健康教育者传播癌症预防和控制的最佳做法 （CHE）.该中心将利用各种方式与19家FHCSD诊所的患者和医疗服务提供者进行沟通。 传播战略，以预防和控制癌症。我们正在使用的质量在连续的 癌症护理框架，以指导我们的干预和评估外展核心活动。这一框架 有效地解决了癌症筛查和诊断解决所需步骤的复杂性， 癌症相关异常为了确保成功，我们组建了一个多学科团队，包括医生- 科学家、行为科学家、医疗保健提供者和公共卫生倡导者， 发展多层次的社区和诊所干预措施，促进癌症预防， 西班牙裔/拉丁裔社区的控制。

OUTREACH CORE ABSTRACT Hispanics/Latinos are at higher risk for late stage cancer, and worse survival after diagnosis, compared to non- Latino whites. Reducing cancer disparities among Hispanics/Latinos requires dissemination of evidence-based strategies for cancer prevention and control and developing evidence to support novel strategies. We postulate that one effective and culturally sensitive approach for reducing cancer burden among Hispanics/Latinos is to link National Cancer Institute (NCI)-designated Cancer Centers and institutions serving underserved populations with Federally Qualified Health Centers (FQHCs). Accordingly, we propose a trilateral partnership among University of California San Diego (UCSD) Moores Cancer Center, San Diego State University (SDSU), and Family Health Centers of San Diego (FHCSD), a FQHC serving over 130,000 individuals annually in San Diego County. We propose to increase screening and diagnostic follow up for breast, cervical, and colorectal cancer among primarily Hispanic/Latino communities through the following aims. First, we will link a community health worker (promotor)-led cancer screening intervention with patient navigation to improve screening rates. The promotora cancer screening intervention builds on findings from a randomized controlled trial aimed to increase cancer screening rates in churchgoing Latinas, and will be extended by including a wide range of community organizations serving Hispanic/Latino communities, as well as Hispanic/Latino men, in outreach efforts. Second, we will optimize complete diagnostic evaluation of abnormal breast, cervical, and colorectal cancer screening tests through implementation of evidence-based best practices. Specifically, in partnership with FHCSD, we will use patient navigation strategies to build upon an existing case management infrastructure to promote complete diagnostic evaluation of abnormal test results. Third, we propose to disseminate best practices for cancer prevention and control through a certified Community Health Educator (CHE). The CHE will interface with patients and healthcare providers in the 19 FHCSD clinics using various dissemination strategies to for cancer prevention and control. We are using the Quality in the Continuum of Cancer Care framework to guide our intervention and evaluation Outreach Core activities. This framework effectively addresses the complexity of steps required for cancer screening and diagnostic resolution of a cancer-related abnormality. To ensure success, we assembled a multidisciplinary team including physician- scientists, behavioral scientists, healthcare providers, and public health advocates with expertise in the development of multi-level community and clinic-based interventions that promote cancer prevention and control in Hispanic/Latino communities.